Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Monthly Archives: April 2023

MissionIRNewsBreaks – RYVYL Inc. (NASDAQ: RVYL) Moving Forward with Spin-Off of Subsidiary, Value Creation Strategy

Posted on April 12, 2023 by MissionIR

RYVYL (NASDAQ: RVYL), a company that leverages the security of the blockchain and USD-pegged stablecoin technology with near-real-time attestation to conduct payment transactions, has initiated a spin-off plan for its wholly owned subsidiary, coyni inc., a stablecoin technology. RYVYL believes … Continue reading →

Posted in RYVYL Inc. RVYL | Leave a comment

MissionIRNewsBreaks – Arizona Metals Corp. (TSX: AMC) (OTCQX: AZMCF) Intersects Broad Interval of VMS Mineralization in First Drill Hole at Western Target

Posted on April 11, 2023 by MissionIR

Arizona Metals (TSX: AMC) (OTCQX: AZMCF) today announced that the first hole (KM-23-104) drilled at the Western Target of the Kay Mine Project intersected 16 metres of stringer to semi-massive sulphide mineralization, including visible copper sulphide (chalcopyrite) and zinc sulphide … Continue reading →

Posted in Data443 Risk Mitigation Inc. ATDS | Leave a comment

MissionIRNewsBreaks – Data443 Risk Mitigation Inc. (ATDS) Secures Another Contract Win from Leading Fintech Giant

Posted on April 11, 2023 by MissionIR

Data443 (OTC: ATDS), a data security and privacy software company for “All Things Data Security,” today announced an additional contract win from one of its largest fintech clients. The client, a leading global organization providing merchant, banking and capital market … Continue reading →

Posted in Data443 Risk Mitigation Inc. ATDS | Leave a comment

CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) Enrolls First Patient in Switzerland in Its Potentially Pivotal Global GBM Trial, Reports No Exposure to SVB Issues

Posted on April 11, 2023 by MissionIR

CNS Pharmaceuticals (NASDAQ: CNSP), a clinical-stage biotechnology company specializing in the development of novel treatments, recently reported the enrolment of the first patient in Switzerland as a participant in its ongoing potentially pivotal global trial evaluating Berubicin for the treatment … Continue reading →

Posted in CNS Pharmaceuticals Inc. CNSP | Leave a comment

MissionIRNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Enrolls Over 100 Patients in Potentially Pivotal Berubicin Study

Posted on April 10, 2023 by MissionIR

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, today announced that more than 100 patients have been enrolled in the company’s potentially … Continue reading →

Posted in CNS Pharmaceuticals Inc. CNSP | Leave a comment

MissionIRNewsBreaks – EverGen Infrastructure Corp. (TSX.V: EVGN) (OTCQX: EVGIF) Driving RNG Adoption in North America

Posted on April 10, 2023 by MissionIR

EverGen (TSX.V: EVGN) (OTCQX: EVGIF) is a leading Canadian renewable energy company and Canada’s renewable natural gas (“RNG”) infrastructure platform. The company is focused on achieving a net-zero future by leveraging the power of RNG, a carbon-neutral alternative to natural … Continue reading →

Posted in EverGen Infrastructure Corp. EVGIF | Leave a comment

MissionIRNewsBreaks – Arizona Metals Corp. (TSX: AMC) (OTCQX: AZMCF) Leveraging Kay Mine Project to Catch the Eye of Mid-Tier Base and Precious Metal Producers

Posted on April 10, 2023 by MissionIR

Arizona Metals (TSX: AMC) (OTCQX: AZMCF), a mineral exploration company engaged in advancing precious and base metal deposits, chose potential historical high-grade copper deposits in Arizona, a stable jurisdiction with a long history of mining copper. “In the Fraser Institute’s … Continue reading →

Posted in Arizona Metals Corp. AZMCF | Leave a comment

D-Wave Quantum Inc. (NYSE: QBTS) Provides Practical Quantum Computing Solutions to Help Companies Improve Operational Efficiencies and Navigate Complexity

Posted on April 10, 2023 by MissionIR

D-Wave Quantum (NYSE: QBTS), a leader in quantum computing systems, software and services, focused on delivering value to customers via practical quantum applications for problems such as logistics, artificial intelligence, materials sciences, drug discovery, scheduling, fault detection, and financial modeling, … Continue reading →

Posted in D-Wave Quantum Inc. QBTS | Leave a comment

Lexaria Bioscience Corp. (NASDAQ: LEXX) Revolutionizing Drug Delivery Potential for Active Pharmaceutical Ingredients Using Patented DehydraTECH(TM) Technology

Posted on April 10, 2023 by MissionIR

Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug delivery platforms, has developed a disruptive drug delivery technology with multiple opportunities for success in cannabinoids, oral nicotine and other active pharmaceutical ingredients (“APIs”). Lexaria’s patented DehydraTECH(TM) technology is a formulation … Continue reading →

Posted in Lexaria Bioscience Corp. LEXX | Leave a comment

MissionIRNewsBreaks – Knightscope, Inc. (NASDAQ: KSCP) Announces New Sales, Security Robot Deployment

Posted on April 6, 2023 by MissionIR

Knightscope (NASDAQ: KSCP), a leading developer of autonomous security robots (“ASRs”) and blue light emergency communication systems, received three new purchase orders for its K1 emergency communication systems. The company also deployed another K5 ASR at a healthcare facility. This … Continue reading →

Posted in Knightscope Inc. KSCP | Leave a comment